Gilead Sciences, Inc. (GILD) Profit Margins
Over the twelve months to 2026-06-30, Gilead Sciences, Inc. (GILD) had gross margin 79.6%, operating margin -8.2%, net margin -10.6%, free cash flow margin 42.5%, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
GILDGilead Sciences, Inc.Follow GILD — free
—
Price chart with a free account
- Market cap
- 193.5B
- P/E TTM
- —
- Dividend yield
- 2.1%
- 52-week
- —
- Next earnings
- 29 Oct, in 5 days
| Line | FY2009 Dec 09 | FY2013 Dec 13 | FY2014 Dec 14 | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 77.2% | 74.5% | 84.8% | 87.7% | 86.0% | 83.3% | 78.1% | 79.2% | 81.5% | 75.8% | 79.3% | 76.0% | 78.3% | 78.8% | 79.6% | |
| Operating margin | 50.3% | 40.4% | 61.3% | 68.0% | 58.0% | 54.1% | 37.1% | 19.1% | 16.5% | 36.3% | 26.9% | 28.0% | 5.8% | 34.0% | -8.2% | |
| Net margin | 37.6% | 27.5% | 48.6% | 55.5% | 44.4% | 17.7% | 24.7% | 24.0% | 0.5% | 22.8% | 16.8% | 20.9% | 1.7% | 28.9% | -10.6% | |
| FCF margin | 40.6% | 26.5% | 49.3% | 62.8% | 53.6% | 43.3% | 33.8% | 37.1% | 30.5% | 39.6% | 30.6% | 27.4% | 35.8% | 32.1% | 42.5% |
USD billions · SEC XBRL
Gilead Sciences, Inc. — questions
- What is Gilead Sciences, Inc.'s gross margin?
- 79.6% over the twelve months to 2026-06-30.
- What is Gilead Sciences, Inc.'s operating margin?
- -8.2% over the twelve months to 2026-06-30.
- What is Gilead Sciences, Inc.'s net profit margin?
- -10.6% over the twelve months to 2026-06-30.
Every figure on this page comes from Gilead Sciences, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.